A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases

BACKGROUND: There is significant interest in the use of stereotactic ablative radiotherapy (SABR) as a treatment modality for liver metastases. A variety of SABR fractionation schemes are in clinical use. We conducted a phase I dose-escalation study to determine the maximum tolerated dose of single-...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ann Surg Oncol
Auteurs principaux: Meyer, Jeffrey J., Foster, Ryan D., Lev-Cohain, Naama, Yokoo, Takeshi, Dong, Ying, Schwarz, Roderich E., Rule, William, Tian, Jing, Xie, Yang, Hannan, Raquibul, Nedzi, Lucien, Solberg, Timothy, Timmerman, Robert
Format: Artigo
Langue:Inglês
Publié: Springer US 2015
Sujets:
Hepatobiliary Tumors
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4695498/
https://ncbi.nlm.nih.gov/pubmed/25963478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-015-4579-z
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires